Department of Clinical Sciences and Community Health (DISCCO), University of Milan, Milan, Italy.
Department of Medicine and Surgery, University of Milan-Bicocca, Monza, Italy.
BMC Pediatr. 2024 Feb 23;24(1):139. doi: 10.1186/s12887-024-04623-3.
Japanese Kawasaki disease (KD) risk scores cannot be adopted in non-Japanese patients. In North American populations a baseline coronary artery Z-score > 2 and the Son score are associated with coronary artery aneurysms (CAAs) at 4 and 8 weeks from disease onset. In European populations, the Kawanet and Kawanet-echo scores are associated with intravenous immunoglobulin resistance. This study aims to evaluate the association between KD risk scores and baseline coronary artery Z-scores with CAAs at one, two, and six months in a European population.
Historical cohort study of all the children diagnosed with KD in a tertiary care hospital in Milan, Italy, between 1st January 2015 and 31st May 2021. Univariate and multivariate (adjusting for age and corticosteroid therapy) logistic regression analyses were used to study the association between the risk scores, a baseline Z-score ≥ 2 and ≥ 2.5 with CAAs.
Eighty-nine patients were diagnosed with KD at our Centre, and 12 were excluded based on the exclusion criteria. We included 77 patients, 51 (66%) males, and 26 (34%) females, with a median age at presentation of 27 months (IQR 13-46). A baseline Z-score ≥ 2 was correlated with CAAs at one and two-month follow-ups (odds ratio (OR) 10, 95% confidence interval (CI) 2-72, and OR 18, CI 3-357) but not at six-month follow-up. The Son score showed an association with one and two-month follow-up CAAs (OR 3, CI 1.3-7, and OR 3, CI 1.3-8) but not with a six-month follow-up.
Patients with a baseline Z-score ≥ 2 are at higher risk for CAAs in the long term. The Son score should be tested in larger European samples. Further studies should keep the observational periods longer than 8 weeks from KD onset.
日本川崎病(KD)风险评分不能用于非日本患者。在北美人群中,基线冠状动脉 Z 评分>2 和 Son 评分与发病后 4 周和 8 周的冠状动脉瘤(CAA)相关。在欧洲人群中,Kawanet 和 Kawanet-echo 评分与静脉注射免疫球蛋白抵抗相关。本研究旨在评估 KD 风险评分与基线冠状动脉 Z 评分与欧洲人群发病后 1、2 和 6 个月的 CAA 之间的相关性。
对 2015 年 1 月 1 日至 2021 年 5 月 31 日期间在意大利米兰一家三级保健医院诊断为 KD 的所有儿童进行历史队列研究。采用单变量和多变量(调整年龄和皮质类固醇治疗)逻辑回归分析来研究风险评分、基线 Z 评分≥2 和≥2.5 与 CAA 之间的相关性。
我们中心诊断出 89 例 KD 患儿,根据排除标准排除了 12 例患儿。我们纳入了 77 例患儿,其中男性 51 例(66%),女性 26 例(34%),发病时的中位年龄为 27 个月(IQR 13-46)。基线 Z 评分≥2 与发病后 1 个月和 2 个月的 CAA 相关(优势比(OR)10,95%置信区间(CI)2-72,OR 18,CI 3-357),但与 6 个月随访时无关。Son 评分与发病后 1 个月和 2 个月的 CAA 相关(OR 3,CI 1.3-7,OR 3,CI 1.3-8),但与 6 个月随访时无关。
基线 Z 评分≥2 的患者发生 CAA 的风险更高。Son 评分应在更大的欧洲样本中进行测试。进一步的研究应保持观察期长于 KD 发病后 8 周。